Department of Chemical Engineering and the David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Tissue Eng Part B Rev. 2012 Jun;18(3):155-66. doi: 10.1089/ten.TEB.2011.0553. Epub 2012 Feb 8.
This report presents a detailed update to our 2008 publication on the tissue engineering (TE) and stem cell industry. Data are reported through mid 2011 showing an almost three-fold growth in commercial sales over the past 4 years. In addition, the number of companies selling products or offering services has increased over two-fold to 106, and they are generating a remarkable $3.5 billion in sales. Overall, the TE and stem cell sector is spending $3.6 billion and employing almost 14,000 employees. These data suggest the TE and stem cell industry has stabilized and is on a path pointing toward continued success.
本报告对我们 2008 年关于组织工程(TE)和干细胞产业的出版物进行了详细更新。数据截至 2011 年年中,显示过去 4 年商业销售额增长了近两倍。此外,销售产品或提供服务的公司数量增加了两倍多,达到 106 家,销售额达到 35 亿美元。总的来说,TE 和干细胞领域的支出为 36 亿美元,雇佣了近 14000 名员工。这些数据表明,TE 和干细胞产业已经稳定下来,并走上了持续成功的道路。